The double downgrade from a mid-tier firm is a caution flag, but the extreme PT outlier ($931 vs $485 mean) and positive EPS revisions suggest the downgrade may be a timing call rather than a fundamental negative. Traders should treat this as a neutral signal — the bullish consensus and institutional buying outweigh HSBC's average track record.
Price Chart
Executive Summary
HSBC double-downgraded Intuitive Surgical (ISRG) from Buy to Hold on July 30, 2026, with a price target of $931, representing 163.7% upside from the current $353.10. HSBC has a 55% accuracy rate on 261 calls with a 5.5% average return, placing it near the middle of covering firms. The consensus on ISRG is heavily bullish: 28 of 40 analysts rate it Buy or Strong Buy, 11 Hold, and 1 Sell. The mean price target is $484.60, median $485, high $685, low $324 — HSBC's $931 target is far above the consensus mean. Momentum is balanced with 1 upgrade and 1 downgrade in the past 30 days. EPS revisions have been positive for the current quarter and year, with 2 upward revisions in the last 30 days for both periods. Insider selling by EVP Brosius Mark occurred in small amounts ($9K-$10K) on multiple dates, likely routine. The double downgrade from a mid-tier firm is a contrarian signal against a bullish consensus, but the extreme PT suggests HSBC still sees significant long-term value.
Impact Score
Consensus & Targets
Consensus is strongly bullish: 11 Strong Buy, 17 Buy, 11 Hold, 1 Sell, 0 Strong Sell across 40 analysts. The overwhelming majority (70%) rate ISRG a Buy or Strong Buy, with only 2.5% at Sell.
Mean PT is $484.60, median $485, high $685, low $324. Current price $353.10 implies 37.2% upside to the mean. HSBC's $931 target is 92% above the mean and 36% above the high consensus target, making it an extreme outlier.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-30 | HSBC | downgrade | Hold | $931.00 |
| 2026-07-17 | Raymond James | maintain | Outperform | $483.00 |
| 2026-07-17 | Piper Sandler | reiterate | Overweight | $470.00 |
| 2026-07-17 | JP Morgan | maintain | Overweight | $450.00 |
| 2026-07-17 | Mizuho | maintain | Neutral | $400.00 |
| 2026-07-17 | Wells Fargo | maintain | Overweight | $487.00 |
| 2026-07-17 | TD Cowen | maintain | Buy | $485.00 |
| 2026-07-17 | Evercore ISI Group | maintain | In-Line | $375.00 |
| 2026-07-17 | RBC Capital | maintain | Outperform | $575.00 |
| 2026-07-17 | Stifel | maintain | Buy | $550.00 |
30-day analyst activity shows 1 upgrade and 1 downgrade (the HSBC action). EPS revision trend is positive: current quarter saw 2 upward revisions in 30 days (EPS from $2.59 to $2.64), current year saw 2 upward revisions (EPS from $10.42 to $10.79). Next quarter and next year also show minor upward revisions. Estimates are being revised higher overall.
Firm Track Record — HSBC
HSBC accuracy: 55% on 261 calls | avg return: 5.5%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Morgan Stanley | 100% | 3/3 | 9.9% | top tier |
| Baird | 100% | 5/5 | 12.1% | top tier |
| Stifel | 100% | 4/4 | 11.7% | top tier |
| BTIG | 91% | 10/11 | 14.5% | top tier |
| Evercore ISI Group | 86% | 6/7 | 9.9% | top tier |
| Piper Sandler | 75% | 6/8 | 7.9% | top tier |
| RBC Capital | 71% | 5/7 | 6.3% | top tier |
| JP Morgan | 67% | 2/3 | 4.8% | top tier |
| Barclays | 67% | 2/3 | 11.3% | top tier |
| Truist Securities | 64% | 7/11 | 3.6% | top tier |
HSBC has a 55% accuracy rate on 261 calls with a 5.5% average return, ranking it in the middle tier. Top-performing firms on ISRG include Morgan Stanley (100% on 3 calls, 9.9% avg return), Baird (100% on 5 calls, 12.1%), and Stifel (100% on 4 calls, 11.7%). The worst performer is Raymond James (33% on 3 calls, -0.9% avg return). HSBC's call is contrarian to the bullish consensus.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $2.64 | $2.53 — $2.76 | $2.9B | ↑1 ↓0 |
| +1q | $2.84 | $2.72 — $3.02 | $3.2B | ↑1 ↓0 |
| 0y | $10.79 | $10.66 — $11.08 | $11.8B | ↑1 ↓0 |
| +1y | $12.07 | $11.28 — $12.72 | $13.3B | ↑0 ↓0 |
Cross-Platform Signals
Insider trades show EVP Brosius Mark sold small amounts ($9K-$10K) on five dates from June 11 to July 29, 2026 — routine, non-cluster sales with no predictive power. No congressional trades. Institutional activity is bullish: five funds added positions with increases of 30-95%. Short interest is elevated at 55.1% of TRF volume, indicating bearish positioning. The analyst downgrade diverges from institutional buying and positive EPS revisions but aligns with high short interest.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | Insider Cluster | $382.29 $398.30 | ▲ +4.19% | ▲ +1.62% | $391.95 (+2.53%) |
Aug 19, 2026 6w ago | Insider Cluster | $374.48 $367.07 | ▼ −1.98% | ▼ −3.09% | $391.95 (+4.67%) |
Aug 13, 2026 7w ago | Court Ruling | $401.27 $374.48 | ▲ +6.68% | ▲ +4.71% | $391.95 (+2.32%) |
Aug 12, 2026 7w ago | ANALYST-UPGRADE | $401.27 $397.72 | ▼ −0.88% | ▼ −0.44% | $391.95 (−2.32%) |
Aug 12, 2026 7w ago | Insider Cluster | $401.27 $397.72 | ▼ −0.88% | ▼ −0.44% | $391.95 (−2.32%) |
Aug 11, 2026 7w ago | Insider Cluster | $401.27 $397.72 | ▼ −0.88% | ▼ −0.44% | $391.95 (−2.32%) |
Jul 30, 2026 9w ago | ANALYST-DOWNGRADE | $352.97 $373.71 | ▲ +5.88% | ▲ +2.25% | $391.95 (+11.04%) |
Jul 16, 2026 11w ago | Press Release | $345.42 $332.02 | ▼ −3.88% | ▼ −3.19% | $391.95 (+13.47%) |
Jul 9, 2026 12w ago | ANALYST-UPGRADE | $411.55 $402.33 | ▼ −2.24% | ▼ −2.11% | $391.95 (−4.76%) |
Jun 12, 2026 15w ago | Insider Cluster | $416.55 $402.95 | ▼ −3.26% | ▼ −1.88% | $391.95 (−5.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access